# ABANTA
> **NDA221024** · New Drug Application · Sponsor: AZURITY · Approved 2026-06-29
## Drug
- **FDA Application Number:** NDA221024
- **Application type:** New Drug Application
- **Brand name:** ABANTA
- **Generic name:** Apixaban
- **Active ingredients:** APIXABAN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AZURITY
- **First approval:** 2026-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=221024)
---
*MORVS · CC0 1.0*